Who founded Volumetric?

Volumetric was founded by Jordan Miller, Bagrat Grigoryan.

Who are Volumetric's investors?

Volumetric's investors include Gaingels, GoAhead Ventures, Harmonix Fund, Helios Capital, Joyance Partners, Jude Gomila, Methuselah Foundation, Methuselah Funds and 20 more.

Who acquired Volumetric?

Volumetric was acquired by 3D Systems.

Where is Volumetric headquartered?

Volumetric is headquartered in Houston, US.

Volumetric

acquired by 3D SystemsYC W20

Houston, US · 5 employees · 29 known investors

Find your way into Volumetric

Paths you didn't know you had: your email and LinkedIn already hold routes to the Volumetric team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs. The company operates a bioprinting facility in Houston, Texas focused on advancing technologies for tissue engineering and bioprinted constructs.

Also known as Volumetric Biotechnologies, Inc · Volumetric Biotechnologies, Inc.

Biotech Deep Tech Healthtech Medical Devices HealthcareUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W20)

Jordan Miller President2018–2021Jordan Miller studied biology at MIT (B.S., 2003) and bioengineering at Rice University (Ph.D., 2008). He founded Volumetric to develop 3D bioprinting technology for organ manufacturing.

Bagrat Grigoryan COO2018–2021Bagrat Grigoryan holds a PhD in Bioengineering from Rice University, where as an NSF GRFP Fellow he developed light-based bioprinting methods for cellular architectures in hydrogels. He co-founded Volumetric, which was acquired by 3D Systems, and currently advises early-stage biotech founders on academic spinouts.

Investors · 29

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: Y Combinator's founder network · gaingels.com · Not right? Tell us

GoAhead Ventureslisted by GoAhead VenturesMenlo Park · $500K – $1M

How we know: the VCSheet dataset · Y Combinator's founder network · Not right? Tell us

Harmonix Fundlisted by Harmonix FundLa Quinta

How we know: Harmonix Fund's portfolio page · Y Combinator's founder network · Not right? Tell us

Helios Capitallisted by Helios CapitalMiami · $25K – $1Mvia Ryan Kriser · inferred

How we know: the VCSheet dataset · Not right? Tell us

Joyance Partnerslisted by Joyance PartnersBerlin

How we know: Y Combinator's founder network · joyancepartners.com · Not right? Tell us

Jude Gomilalisted by Jude GomilaLynnwood

How we know: Jude Gomila's portfolio page · Not right? Tell us

Methuselah Foundationlisted by Methuselah FoundationSpringfield

How we know: Methuselah Foundation's portfolio page · Y Combinator's founder network · Not right? Tell us

Methuselah Fundslisted by Methuselah FundsSpringfield

How we know: Y Combinator's founder network · Not right? Tell us

Sand Hill Angelslisted by Sand Hill AngelsMenlo Park · $50K – $2M

How we know: Y Combinator's founder network · Not right? Tell us

Social Startslisted by Social StartsSan Francisco

How we know: Social Starts's portfolio page · the VCSheet dataset · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

BiovergereportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

BoxOne VenturesreportedMontréal · $500K

How we know: the VCSheet dataset · Not right? Tell us

Buff Gold VenturesreportedBoulder

How we know: design-engineering.com · Not right? Tell us

Caruso VenturesreportedColorado · $500K – $2.5M

How we know: design-engineering.com · Not right? Tell us

ChainFund CapitalreportedSilicon Valley

How we know: a partner's Signal profile · Y Combinator's founder network · Not right? Tell us

LDV CapitalreportedNew York · $500K – $1.5M

How we know: funding news · Not right? Tell us

Liquid VenturesreportedSan Francisco · $250K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

MetaplanetreportedTallinn · $500K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

MyAsiaVCreportedSeattle

How we know: Y Combinator's founder network · Not right? Tell us

Network VCreportedMenlo Park

How we know: Y Combinator's founder network · Not right? Tell us

Nimble Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Republic VenturesreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Rockies Venture ClubreportedDenver · $100K – $500K

How we know: design-engineering.com · Not right? Tell us

Sharding Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

TechU VenturesreportedCedarhurst

How we know: Y Combinator's founder network · Not right? Tell us

TMC Venture FundreportedHouston

How we know: Y Combinator's founder network · Not right? Tell us

TMT Investmentsreported

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 1

The Deming Center Venture Fund

Funding

SEC filings, press & company announcements

Undisclosed amountseed roundNov 2022 · 2 sources
Buff Gold Ventures (lead), Caruso Ventures, Rockies Venture Club, The Deming Center Venture Fund
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

Synthio LabsSynthio Labs develops AI-powered synthesis and clinical interpretation systems for pharmaceutical interactions, offering text, voice, and video interfaces designed for healthcare professionals and patients that integrate FDA labels, drug mechanisms, and clinical literature.

Adventris PharmaceuticalsAdventris is a biotechnology company developing cancer immunotherapy treatments.

Granza BioGranza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

Pirouette PharmaPirouette develops OnePush, a fully automatic hidden-needle auto-injector platform paired with drug programs across chronic and rescue care indications. The company is advancing clinical-stage programs in naloxone, epinephrine, promethazine, and methotrexate while scaling U.S. automated manufacturing and securing IP protection through 2045.

FrekilFrekil automates real-world evidence generation for pharmaceutical and healthcare research, using AI agents to build patient cohorts, design studies, and generate statistical analyses from existing clinical data. The platform enables epidemiological workflows across drug safety monitoring, comparative effectiveness, label expansion, and trial feasibility assessments.

Companies working in the same space as Volumetric.

Legal entities · 2

corporate structure

Volumetric Biotechnologies, Inc

Volumetric Biotechnologies, Inc.

Frequently asked questions

What does Volumetric do?: Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs. The company operates a bioprinting facility in Houston, Texas focused on advancing technologies for tissue engineering and bioprinted constructs.
Who founded Volumetric?: Volumetric was founded by Jordan Miller, Bagrat Grigoryan.
Who are Volumetric's investors?: Volumetric's investors include Gaingels, GoAhead Ventures, Harmonix Fund, Helios Capital, Joyance Partners, Jude Gomila, Methuselah Foundation, Methuselah Funds and 20 more.
Who acquired Volumetric?: Volumetric was acquired by 3D Systems.
Where is Volumetric headquartered?: Volumetric is headquartered in Houston, US.